CircRnas in atherosclerosis, with special emphasis on the spongy effect of circRnas on miRnas

References

• Engelen SE, Robinson AJB, YX Z, et al. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol. 2022;19(8):522–542.
   PubMed Web of Science ®Google Scholar
• Tabas I, García-Cardeña G, Owens GK Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015;209(1):13–22.
   Google Scholar
• Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–241.
   PubMed Web of Science ®Google Scholar
• JR Z, HJ S. LncRnas and circular RNAs as endothelial cell messengers in hypertension: mechanism insights and therapeutic potential. Mol Biol Rep. 2020;47(7):5535–5547.
   PubMed Web of Science ®Google Scholar
• DF R-B, Maira A, Sibinga NES. The atypical cadherin FAT1 limits mitochondrial respiration and proliferation of vascular smooth muscle cells. Front Cardiovasc Med. 2022;9:905717.
   PubMed Web of Science ®Google Scholar
• Worssam MD, Jørgensen HF. Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseases. Biochem Soc Trans. 2021;49(5):2101–2111.
   PubMed Web of Science ®Google Scholar
• Basatemur GL, Jørgensen HF, Clarke MCH, et al. Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 2019;16(12):727–744.
   PubMed Web of Science ®Google Scholar
• Li T, Wang B, Ding H, et al. Effect of extracellular vesicles from multiple cells on vascular smooth muscle cells in atherosclerosis. Front Pharmacol. 2022;13:857331.
   PubMed Web of Science ®Google Scholar
• Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428–442.
   PubMed Web of Science ®Google Scholar
• Gu J, Su C, Huang F, et al. Past, present and future: the relationship between circular RNA and immunity. Front Immunol. 2022;13:894707.
   PubMed Web of Science ®Google Scholar
• Jiao S, Wu S, Huang S, et al. Advances in the identification of circular RNAs and research into circrnas in human diseases. Front Genet. 2021;12:665233.
   PubMed Web of Science ®Google Scholar
• Li H, Liu X, Sun N, et al. Differentially expressed circular non-coding RNAs in atherosclerotic aortic vessels and their potential functions in endothelial injury. Front Cardiovasc Med. 2021;8:657544.
   PubMed Web of Science ®Google Scholar
• Kang L, Jia H, Huang B, et al. Identification of differently expressed mRNAs in atherosclerosis reveals CDK6 is Regulated by circHipk3/mir-637 axis and promotes cell growth in human vascular smooth muscle cells. Front Genet. 2021;12:596169.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Wen Y, Chun Y, Lian ZQ, et al. circRna‑0006896‑mir1264‑dnmt1 axis plays an important role in carotid plaque destabilization by regulating the behavior of endothelial cells in atherosclerosis. Mol Med Rep. 2021;23(5):311.
   PubMed Web of Science ®Google Scholar
• Caba L, Florea L, Gug C, et al. Circular RNA-is the circle perfect? Biomolecules. 2021;11(12):1755.
   PubMed Web of Science ®Google Scholar
• Wang L, Shen C, Wang Y, et al. Identification of circular RNA Hsa_circ_0001879 and Hsa_circ_0004104 as novel biomarkers for coronary artery disease. Atherosclerosis. 2019;286:88–96.
   PubMed Web of Science ®Google Scholar
• Ji P, Song X, Lv Z. Knockdown of circ_0004104 alleviates oxidized low-density lipoprotein-induced vascular endothelial cell injury by regulating miR-100/TNFAIP8 Axis. J Cardiovasc Pharmacol. 2021;78(2):269–279.
   PubMed Web of Science ®Google Scholar
• Li S, Hu W, Deng F, et al. Identification of Circular RNA hsa_circ_0001599 as a novel biomarker for large-artery atherosclerotic stroke. DNA Cell Biol. 2021;40(3):457–468.
   PubMed Web of Science ®Google Scholar
• Wen C, Li B, Nie L, et al. Emerging Roles of extracellular vesicle-delivered circular RNAs in atherosclerosis. Front Cell Dev Biol. 2022;10:804247.
   PubMed Web of Science ®Google Scholar
• LL Z. CircRNA-PTPRA promoted the progression of atherosclerosis through sponging with miR-636 and upregulating the transcription factor SP1. Eur Rev Med Pharmacol Sci. 2020;24(23):12437–12449.
   PubMed Web of Science ®Google Scholar
• Vilades D, Martínez-Camblor P, Ferrero-Gregori A, et al. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: performance as a biomarker. Faseb J. 2020;34(3):4403–4414.
   PubMed Web of Science ®Google Scholar
• Chen J, Cui L, Yuan J, et al. Circular RNA WDR77 target FGF-2 to regulate vascular smooth muscle cells proliferation and migration by sponging miR-124. Biochem Biophys Res Commun. 2017;494(1–2):126–132.
   PubMed Web of Science ®Google Scholar
• Huang JG, Tang X, Wang JJ, et al. A circular RNA, circUSP36, accelerates endothelial cell dysfunction in atherosclerosis by adsorbing miR-637 to enhance WNT4 expression. Bioengineered. 2021;12(1):6759–6770.
   PubMed Web of Science ®Google Scholar
• Ding P, Ding Y, Tian Y, et al. Circular RNA circ_0010283 regulates the viability and migration of oxidized low‑density lipoprotein‑induced vascular smooth muscle cells via an miR‑370‑3p/HMGB1 axis in atherosclerosis. Int J Mol Med. 2020;46(4):1399–1408.
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhu Y, Zhang J, et al. Hsa-circ_0010283 regulates oxidized low-density lipoprotein-induced proliferation and migration of vascular smooth muscle cells by targeting the miR-133a-3p/pregnancy-associated plasma protein a axis. Circ J. 2020;84(12):2259–2269.
   PubMed Web of Science ®Google Scholar
• Gao Y, Li G, Fan S, et al. Circ_0093887 upregulates CCND2 and SUCNR1 to inhibit the ox-LDL-induced endothelial dysfunction in atherosclerosis by functioning as a miR-876-3p sponge. Clin Exp Pharmacol Physiol. 2021;48(8):1137–1149.
   PubMed Web of Science ®Google Scholar
• Liang B, Li M, Deng Q, et al. CircRNA ZNF609 in peripheral blood leukocytes acts as a protective factor and a potential biomarker for coronary artery disease. Ann Transl Med. 2020Jun;812:741
   PubMed Web of Science ®Google Scholar
• Bazan HA, Hatfield SA, Brug A, et al. Carotid plaque rupture is accompanied by an increase in the ratio of serum circR-284 to miR-221 levels. Circ Cardiovasc Genet. 2017;10(4):e001720.
   PubMedGoogle Scholar
• Bentzon JF, Otsuka F, Virmani R, et al. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–1866.
   PubMed Web of Science ®Google Scholar
• Xu S, Pelisek J, Jin ZG. Atherosclerosis is an epigenetic disease. Trends Endocrinol Metab. 2018;29(11):739–742.
   PubMed Web of Science ®Google Scholar
• Wu WP, Zhou MY, Liu DL, et al. circGNAQ, a circular RNA enriched in vascular endothelium, inhibits endothelial cell senescence and atherosclerosis progression. Mol Ther Nucleic Acids. 2021;26:374–387.
   PubMedGoogle Scholar
• Hu F, Chen X, Gao J, et al. CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells. Vascul Pharmacol. 2021;139:106887.
   PubMed Web of Science ®Google Scholar
• Xu S, Kamato D, Little PJ, et al. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics. Pharmacol Ther. 2019;196:15–43.
   PubMed Web of Science ®Google Scholar
• Shen L, Hu Y, Lou J, et al. CircRNA‑0044073 is up-regulated in atherosclerosis and increases the proliferation and invasion of cells by targeting miR‑107. Mol Med Rep. 2019;19(5):3923–3932.
   PubMed Web of Science ®Google Scholar
• Shang L, Quan A, Sun H, et al. MicroRNA-148a-3p promotes survival and migration of endothelial cells isolated from apoe deficient mice through restricting circular RNA 0003575. Gene. 2019;711:143948.
   PubMed Web of Science ®Google Scholar
• Liang G, Chen S, Xin S, et al. Overexpression of hsa_circ_0001445 reverses oxLdl‑induced inhibition of HUVEC proliferation via SRSF1. Mol Med Rep. 2021;24(1):507.
   PubMed Web of Science ®Google Scholar
• Li CY, Ma L, Yu B. Circular RNA hsa_circ_0003575 regulates oxLDL induced vascular endothelial cells proliferation and angiogenesis. Biomed Pharmacother. 2017;95:1514–1519.
   PubMed Web of Science ®Google Scholar
• Chen G, Li Y, Zhang A, et al. Circular RNA circ-BANP regulates oxidized low-density lipoprotein-induced endothelial cell injury through targeting the miR-370/thioredoxin-interacting protein axis. J Cardiovasc Pharmacol. 2021;77(3):349–359.
   PubMed Web of Science ®Google Scholar
• Han L, Li D, Hang Y, et al. Downregulation of hsa_circ_0004543 activates oxldl-induced vascular endothelial cell proliferation and angiogenesis. Front Genet. 2021;12:632164.
   PubMed Web of Science ®Google Scholar
• Peng H, Sun J, Li Y, et al. Circ-USP9X inhibition reduces oxidized low-density lipoprotein-induced endothelial cell injury via the microRNA 599/chloride intracellular channel 4 axis. J Cardiovasc Pharmacol. 2021;78(4):560–571.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li W, Li H, et al. Circ_usp36 silencing attenuates oxidized low-density lipoprotein-induced dysfunction in endothelial cells in atherosclerosis through mediating miR-197-3p/robo1 axis. J Cardiovasc Pharmacol. 2021;78(5):e761–772.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Lu YH, Wang X, et al. Circ_usp36/mir-182-5p/klf5 axis regulates the ox-LDL-induced injury in human umbilical vein smooth muscle cells. Am J Transl Res. 2020;12(12):7855–7869.
   PubMed Web of Science ®Google Scholar
• Ge Y, Liu W, Yin W, et al. Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cells. Bioengineered. 2021;12(2):10837–10848. DOI:10.1080/21655979.2021.1989260
   PubMed Web of Science ®Google Scholar
• Zhang W, Sui Y. CircBPTF knockdown ameliorates high glucose-induced inflammatory injuries and oxidative stress by targeting the miR-384/LIN28B axis in human umbilical vein endothelial cells. Mol Cell Biochem. 2020;471(1–2):101–111.
   PubMed Web of Science ®Google Scholar
• Peng K, Jiang P, Du Y, et al. Oxidized low-density lipoprotein accelerates the injury of endothelial cells via circ-USP36/miR-98-5p/vcam1 axis. IUBMB Life. 2021;73(1):177–187. DOI:10.1002/iub.2419
   PubMed Web of Science ®Google Scholar
• Miao J, Wang B, Shao R, et al. CircUSP36 knockdown alleviates oxidized low‑density lipoprotein‑induced cell injury and inflammatory responses in human umbilical vein endothelial cells via the miR‑20a‑5p/ROCK2 axis. Int J Mol Med. 2021;47(4):40.
   PubMed Web of Science ®Google Scholar
• Qin M, Wang W, Zhou H, et al. Circular RNA circ_0003645 silencing alleviates inflammation and apoptosis via the NF-κB pathway in endothelial cells induced by oxLDL. Gene. 2020;755:144900.
   PubMed Web of Science ®Google Scholar
• Su Q, Dong X, Tang C, et al. Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: circulating RNAs could explain atherosclerosis disease progression. Open Med (Wars). 2021;16(1):558–569.
   PubMedGoogle Scholar
• Shi P, Ji H, Zhang H, et al. circANRIL reduces vascular endothelial injury, oxidative stress and inflammation in rats with coronary atherosclerosis. Exp Ther Med. 2020;20(3):2245–2251.
   PubMed Web of Science ®Google Scholar
• Song CL, Wang JP, Xue X, et al. Effect of circular ANRIL on the inflammatory response of vascular endothelial cells in a rat model of coronary atherosclerosis. Cell Physiol Biochem. 2017;42(3):1202–1212.
   PubMedGoogle Scholar
• Du N, Li M, Yang D. Hsa_circrna_102541 regulates the development of atherosclerosis by targeting miR-296-5p/plk1 pathway. Ir J Med Sci. 2022;191(3):1153–1159.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu J, Zhang Q, et al. CircRNA RSF1 regulated ox-LDL induced vascular endothelial cells proliferation, apoptosis and inflammation through modulating miR-135b-5p/hdac1 axis in atherosclerosis. Biol Res. 2021;54(1):11.
   PubMed Web of Science ®Google Scholar
• Wang G, Li Y, Liu Z, et al. Circular RNA circ_0124644 exacerbates the ox-LDL-induced endothelial injury in human vascular endothelial cells through regulating PAPP-A by acting as a sponge of miR-149-5p. Mol Cell Biochem. 2020;471(1–2):51–61.
   PubMed Web of Science ®Google Scholar
• Wei Z, Ran H, Yang C. CircRSF1 contributes to endothelial cell growth, migration and tube formation under ox-LDL stress through regulating miR-758/CCND2 axis. Life Sci. 2020;259:118241.
   PubMed Web of Science ®Google Scholar
• Liu H, Ma X, Mao Z, et al. Circular RNA has_circ_0003204 inhibits oxLDL-induced vascular endothelial cell proliferation and angiogenesis. Cell Signal. 2020;70:109595.
   PubMed Web of Science ®Google Scholar
• Wan H, You T, Luo W. Circ_0003204 regulates cell growth, oxidative stress, and inflammation in ox-LDL-induced vascular endothelial cells via regulating miR-942-5p/hdac9 axis. Front Cardiovasc Med. 2021;8:646832.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang L, Shen Y. Circ_0004104 knockdown alleviates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells through targeting miR-328-3p/trim14 axis in atherosclerosis. BMC Cardiovasc Disord. 2021;21(1):207.
   PubMed Web of Science ®Google Scholar
• Tiliwaldi H, Tursun A, Tohti A, et al. Circ_0000345 protects endothelial cells from oxidized low-density lipoprotein-induced injury by miR-129-5p/Ten-eleven translocation axis. J Cardiovasc Pharmacol. 2021;77(5):603–613.
   PubMed Web of Science ®Google Scholar
• Li S, Huang T, Qin L, et al. Circ_0068087 silencing ameliorates oxidized low-density lipoprotein-induced dysfunction in vascular endothelial cells depending on miR-186-5p-mediated regulation of roundabout guidance receptor 1. Front Cardiovasc Med. 2021;8:650374.
   PubMed Web of Science ®Google Scholar
• Liu H, Ma X, Wang X, et al. Hsa_circ_0000345 regulates the cellular development of ASMCs in response to oxygenized low-density lipoprotein. J Cell Mol Med. 2020;24(20):11849–11857.
   PubMed Web of Science ®Google Scholar
• Li D, Jin W, Sun L, et al. Circ_0065149 alleviates oxidized low-density lipoprotein-induced apoptosis and inflammation in atherosclerosis by targeting miR-330-5p. Front Genet. 2021;12:590633.
   PubMed Web of Science ®Google Scholar
• Skuratovskaia D, Vulf M, Komar A, et al. Promising directions in atherosclerosis treatment based on epigenetic regulation using microRNAs and long noncoding RNAs. Biomolecules. 2019;9(6):226. DOI:10.3390/biom9060226
   PubMed Web of Science ®Google Scholar
• Peng W, Li T, Pi S, et al. Suppression of circular RNA circDHCR24 alleviates aortic smooth muscle cell proliferation and migration by targeting miR-149-5p/mmp9 axis. Biochem Biophys Res Commun. 2020;529(3):753–759.
   PubMed Web of Science ®Google Scholar
• Yang L, Yang F, Zhao H, et al. Circular RNA circCHFR facilitates the proliferation and migration of vascular smooth muscle via miR-370/foxo1/cyclin D1 pathway. Mol Ther Nucleic Acids. 2019;16:434–441.
   PubMedGoogle Scholar
• Li X, Li L, Dong X, et al. Circ_grn promotes the proliferation, migration, and inflammation of vascular smooth muscle cells in atherosclerosis through miR-214-3p/foxo1 axis. J Cardiovasc Pharmacol. 2021;77(4):470–479.
   PubMed Web of Science ®Google Scholar
• Zhuang JB, Li T, Hu XM, et al. Circ_chfr expedites cell growth, migration and inflammation in ox-LDL-treated human vascular smooth muscle cells via the miR-214-3p/Wnt3/β-catenin pathway. Eur Rev Med Pharmacol Sci. 2020;24(6):3282–3292.
   PubMed Web of Science ®Google Scholar
• Sun C, Li J, Li Y, et al. Circular RNA circUBR4 regulates ox-LDL-induced proliferation and migration of vascular smooth muscle cells through miR-185-5p/frs2 axis. Mol Cell Biochem. 2021;476(11):3899–3910.
   PubMed Web of Science ®Google Scholar
• Ding Y, Tang T, Lu J, et al. Circ_ubr4 knockdown alleviates oxidized low-density lipoprotein-provoked growth and migration of human vascular smooth muscle cells by acting on the miR-637/FOXO4 pathway. J Cardiovasc Pharmacol. 2021;78(4):534–543.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang C, Chen Z, et al. Blocking circ_ubr4 suppressed proliferation, migration, and cell cycle progression of human vascular smooth muscle cells in atherosclerosis. Open Life Sci. 2021;16(1):419–430.
   PubMed Web of Science ®Google Scholar
• Li R, Jiang Q, Zheng Y. Circ_0002984 induces proliferation, migration and inflammation response of VSMCs induced by ox-LDL through miR-326-3p/vamp3 axis in atherosclerosis. J Cell Mol Med. 2021;25(16):8028–8038.
   PubMed Web of Science ®Google Scholar
• Fu X, Niu T, Yang T, et al. CircMAPK1 promotes the proliferation and migration of vascular smooth muscle cells through miR-22-3p/methyl-CpG binding protein 2 axis. Nutr Metab Cardiovasc Dis. 2021;31(7):2189–2198.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Xia L, Fan S, et al. Circular RNA CircMAP3K5 acts as a MicroRNA-22-3p sponge to promote resolution of intimal hyperplasia via tet2-mediated smooth muscle cell differentiation. Circulation. 2021;143(4):354–371. DOI:10.1161/CIRCULATIONAHA.120.049715
   PubMed Web of Science ®Google Scholar
• Fan K, Ruan X, Wang L, et al. Circ_0004872 promotes platelet-derived growth factor-BB-induced proliferation, migration and dedifferentiation in HA-VSMCs via miR-513a-5p/txnip axis. Vascul Pharmacol. 2021;140:106842.
   PubMed Web of Science ®Google Scholar
• Ji N, Wang Y, Gong X, et al. CircMTO1 inhibits ox-LDL-stimulated vascular smooth muscle cell proliferation and migration via regulating the miR-182-5p/rasa1 axis. Mol Med. 2021;27(1):73.
   PubMed Web of Science ®Google Scholar
• Huang Z, Li P, Wu L, et al. Hsa_circ_0029589 knockdown inhibits the proliferation, migration and invasion of vascular smooth muscle cells via regulating miR-214-3p and STIM1. Life Sci. 2020;259:118251.
   PubMed Web of Science ®Google Scholar
• Xu F, Shen L, Chen H, et al. circDENND1B participates in the antiatherosclerotic effect of IL-1β monoclonal antibody in mouse by promoting cholesterol efflux via miR-17-5p/abca1 axis. Front Cell Dev Biol. 2021;9:652032.
   PubMed Web of Science ®Google Scholar
• Gardner SE, Humphry M, Bennett MR, et al. Senescent vascular smooth muscle cells drive inflammation through an interleukin-1α-dependent senescence-associated secretory phenotype. Arterioscler Thromb Vasc Biol. 2015;35(9):1963–1974.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Y, Liao Y, et al. Circular RNA PPP1CC promotes Porphyromonas gingivalis-lipopolysaccharide-induced pyroptosis of vascular smooth muscle cells by activating the HMGB1/TLR9/AIM2 pathway. J Int Med Res. 2021;49(3):300060521996564.
   PubMed Web of Science ®Google Scholar
• Zhao J, He X, Zuo M, et al. Anagliptin prevented interleukin 1β (IL-1β)-induced cellular senescence in vascular smooth muscle cells through increasing the expression of sirtuin1 (SIRT1). Bioengineered. 2021;12(1):3968–3977. DOI:10.1080/21655979.2021.1948289
   PubMed Web of Science ®Google Scholar
• Holdt LM, Stahringer A, Sass K, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016;7:12429.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang Z, Yang S. Circ_rusc2 upregulates the expression of miR-661 target gene SYK and regulates the function of vascular smooth muscle cells. Biochem Cell Biol. 2019;97(6):709–714.
   PubMed Web of Science ®Google Scholar
• YY M, JQ W, XX G, et al. Circ-SATB2 upregulates STIM1 expression and regulates vascular smooth muscle cell proliferation and differentiation through miR-939. Biochem Biophys Res Commun. 2018;505(1):119–125.
   PubMed Web of Science ®Google Scholar
• Yu H, Zhao L, Zhao Y, et al. Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p/igf2 axis. Vascul Pharmacol. 2020;135:106782.
   PubMed Web of Science ®Google Scholar
• Lin DS, Zhang CY, Li L, et al. Circ_robo2/mir-149 axis promotes the proliferation and migration of human aortic smooth muscle cells by activating NF-κB signaling. Cytogenet Genome Res. 2021;161(8–9):414–424.
   PubMed Web of Science ®Google Scholar
• Marchio P, Guerra-Ojeda S, Vila JM, et al. Targeting early atherosclerosis: a focus on oxidative stress and inflammation. Oxid Med Cell Longev. 2019;2019:8563845.
   PubMed Web of Science ®Google Scholar
• Grootaert MOJ, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis. Cardiovasc Res. 2018;114(4):622–634.
   PubMed Web of Science ®Google Scholar
• Wang X, Bai M. CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206/ASPH axis in atherosclerosis cell model in vitro. BMC Cardiovasc Disord. 2021;21(1):51.
   PubMed Web of Science ®Google Scholar
• He Q, Shao D, Hao S, et al. CircSCAP Aggravates oxidized low-density lipoprotein-induced macrophage injury by upregulating PDE3B by miR-221-5p in Atherosclerosis. J Cardiovasc Pharmacol. 2021;78(5):e749–760.
   PubMed Web of Science ®Google Scholar
• Yu F, Zhang Y, Wang Z, et al. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3. Theranostics. 2021;11(11):5404–5417. DOI:10.7150/thno.48389
   PubMed Web of Science ®Google Scholar
• Wei MY, Lv RR, Teng Z. Circular RNA circHIPK3 as a novel circRNA regulator of autophagy and endothelial cell dysfunction in atherosclerosis. Eur Rev Med Pharmacol Sci. 2020;24(24):12849–12858.
   PubMed Web of Science ®Google Scholar
• Liu J, Wei Y, Lin Y, et al. Expression of the circular RNAs in astaxanthin promotes cholesterol efflux from THP-1 cells based on RNA-seq. Genes Nutr. 2021;16(1):13.
   PubMed Web of Science ®Google Scholar
• Guo M, Yan R, Ji Q, et al. IFN regulatory Factor-1 induced macrophage pyroptosis by modulating m6a modification of circ_0029589 in patients with acute coronary syndrome. Int Immunopharmacol. 2020;86:106800.
   PubMed Web of Science ®Google Scholar
• Lin Z, Tang X, Wan J, et al. Functions and mechanisms of circular RNAs in regulating stem cell differentiation. RNA Biol. 2021;18(12):2136–2149.
   PubMed Web of Science ®Google Scholar
• Beck-Joseph J, Lehoux S. Molecular interactions between vascular smooth muscle cells and macrophages in atherosclerosis. Front Cardiovasc Med. 2021;8:737934.
   PubMed Web of Science ®Google Scholar
• Shao X, Liu Z, Liu S, et al. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/mir-135a-5p/clic4 axis in as cell model in vitro. Mol Cell Biochem. 2021;476(4):1783–1795.
   PubMed Web of Science ®Google Scholar
• Qian W, Cai X, Qian Q, et al. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway. Drug Des Devel Ther. 2019;13:2579–2589.
   PubMed Web of Science ®Google Scholar